Mexico participates in Walvax COVID-19 vaccine trials
Media
Dec 7, 2021
adn40
Trials of the Walvax vaccine against COVID-19 are being carried out in Mexico. The product is based on the mRNA, same as the moderna and pfizer vaccines. It is a biologic developed in China and 6,000 volunteers over 18 years of age are being recruited nationally.
Related Links
Sep 7, 2021
Walvax’s modular workshop for SARS-CoV-2 mRNA Vaccine, the first modular mRNA workshop in China, has been delivered
Learn More
Sep 30, 2022
Walvax and Abogen Granted Indonesian Emergency Use Authorization for the SARS-CoV-2 mRNA Vaccine (AWcorna)
Learn More
Oct 21, 2022
Walvax’s Management Member Elected to DCVMN Board
Learn More